|
 |
|
Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.Contains 260 pages and 30 tables
|
 |
|
$2850.00 |
| |
|
|
|
Pap Smear/Papillomavirus (HPV): France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment.The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
|
|
|
$2850.00 |
| |
|
|
|
Analysis of Emerging Cancer Diagnostic Tests
and Strategic Profile of Leading Suppliers
This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
|
|
|
$2800.00 |
| |
|
|
|
Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 80 pages
|
|
|
$2500.00 |
| |
|
|
|
World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$2500.00 |
| |
|
|
|
Analysis of the Argentinean Cancer Diagnostics Market:
Sales Forecasts, Supplier Shares, Competitive Strategies
Analysis of the Argentinean Cancer Diagnostics Market is a new strategic analysis of the major business opportunities emerging in the Argentinean cancer diagnostics market during the next five years. The report examines trends in the Argentinean cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
|
|
|
$2500.00 |
| |
|
|
|
Analysis of Mexican Cancer Diagnostics Market:
Sales Forecasts, Supplier Shares, Competitive Strategies
"Analysis of Mexican Cancer Diagnostics Market" is a new strategic analysis of the major business opportunities emerging in the Mexican cancer diagnostics market during the next five years. The report examines trends in the Mexico cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
|
|
|
$2500.00 |
| |
|
|
|
Italy Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2500.00 |
| |
|
|
|
Cancer Diagnostics Market: Strategic Assessments of Current and Emerging Competitors
This new report from VPGMarketResearch.com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants....
|
|
|
$2500.00 |
| |
|
|
|
Australia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Austria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Belgium Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Bulgaria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Canada Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Cyprus Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Czech Republic Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Denmark Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
Estonia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$2500.00 |
| |
|
|
|
|